Table 1.
Age (mean ± SD) | 81.1 ± 4.1 |
Male, N (%) | 31,332 (98.1%) |
Race, N (%) | |
White | 29,255 (91.6%) |
Black | 2166 (6.8%) |
Other | 530 (1.5%) |
Body mass index (mean ± SD) | 28.1 ± 5.1 |
Comorbid diseases, N (%) | |
Hypertension | 26,362 (82.5%) |
Diabetes | 10,806 (33.8%) |
Prior Stroke | 3512 (11.0%) |
Hyperlipidemia | 20,213 (63.3%) |
Coronary artery disease | 13,604 (42.6%) |
Peripheral vascular disease | 3538 (11.1%) |
Myocardial infarction | 1329 (4.2%) |
Chronic obstructive pulmonary disease | 8149 (25.5%) |
Chronic kidney disease | 5245 (16.4%) |
Heart failure | 9803 (30.7%) |
Anemia | 6514 (20.4%) |
Problem drug/alcohol use | 528 (1.7%) |
Abnormal renal or liver function a | 1862 (5.8%) |
Geriatric impairments, N (%) | |
Dementia | 1498 (4.7%) |
Depression | 5384 (16.9%) |
Arthritis | 8878 (27.8%) |
Prior fall | 1614 (5.1%) |
Dizziness | 1037 (3.3%) |
Visual impairment | 10,586 (33.1%) |
Medications, N (%) | |
Anxiolytic use | 4021 (12.6%) |
Antipsychotic use | 919 (2.9%) |
Anticonvulsant use | 2469 (7.7%) |
Antihypertensive use | 29,713 (93.0%) |
Polypharmacy (≥4 medications) | 27,784 (87.0%) |
INR control | |
Good (>75% TTR) b | 4864 (15.2%) |
Moderate (60–75% TTR) | 9141 (28.6%) |
Labile (<60% TTR) | 17,862 (55.9%) |
Missing | 84 (0.3%) |
Chronic dialysis, renal transplant, cirrhosis, creatinine ≥2.3 mg/dL, total bilirubin ≥2x upper limit of normal (ULN), or AST/ALT ≥3x ULN
TTR = time in therapeutic range